We’ve received some more positive feedback from one of our US pharma clients. Here’s what our client had to say:“Hypha Discovery… read more →
We were delighted to welcome some new recruits to the Hypha family this October. Chloe Herring and John Boyle join… read more →
Hypha publishes review article in ACS Med. Chem. Lett. on the impact of metabolism in drug discovery
Hypha’s paper in ACS Medicinal Chemistry Letters on “Biotransformation: Impact and Application of Metabolism in Drug Discovery” was published in… read more →
Check out a new white paper describing the joint efforts of Hypha and Galchimia, who together successfully synthesised metabolites of… read more →
Hypha were honoured to be asked to contribute a chapter on “Metabolite Generation and Metabolite Characterization by NMR” in the… read more →
This is an exciting opportunity for an intern to spend time on a research project to further exemplify the use… read more →
Hypha are excited to announce they have relocated from Slough to Milton Park in Oxfordshire, one of the largest science… read more →
Metabolites derived from any human flavin-containing monooxygenase (FMO) subtype can now be produced as a service offering at Hypha. Recombinant… read more →
Great to see Hypha recognised for producing a glucuronide metabolite of praliciguat (M3) in the paper just out in the… read more →
We illustrate application of our one-stop metabolite shop in meeting metabolite requirements for various client projects using different techniques in… read more →